Cargando…

P141 Study of prevalence, antifungal profile and predictors of mortality in chronic pulmonary Aspergillosis in a cohort of liver disease patient

POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Chronic pulmonary aspergillosis (CPA) is a neglected cause of respiratory disease even in high-TB burden countries like India. It is a term that includes simple aspergilloma, chronic cavitary pulmonary aspergillosis which is the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kale, Pratibha, Bhattacharyya, Debajyoti, Khillan, Vikas, Sarin, Shiv Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509990/ http://dx.doi.org/10.1093/mmy/myac072.P141

Ejemplares similares

P406 Rise in HIV negative Cryptococcal infection in liver disease patient: epidemiology, risk factor, antifungal susceptibility profile from tertiary care hepatobiliary center
por: Patel, Dhruvi, et al.
Publicado: (2022)

P409 Study of epidemiology, risk factors and antifungal sensitivity pattern of fungal pneumonia in critically ill cirrhotics
por: Singh, Paras, et al.
Publicado: (2022)

P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India
por: Patel, Niharika, et al.
Publicado: (2022)

P004 Neglected risk for of invasive candidiasis: s tudy of distribution, species differentiation and antifungal susceptibility pattern of Candidemia among patients with liver disease
por: Kumar, Pradeep, et al.
Publicado: (2022)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

2047. Study of Molecular epidemiology, risk factor analysis and comparison of diagnostic methods for rapid diagnosis of fungal pneumonia in critically ill cirrhotics
por: Kale, Pratibha Ramchandra, et al.
Publicado: (2018)

S10.4b Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
por: Izumikawa, Koichi
Publicado: (2022)

P459 The Aspergillus lateral flow assay for the diagnosis of chronic pulmonary aspergillosis
por: Peng, Jie, et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

P172 First report of Aspergillus tamarii producing influenza associated invasive pulmonary Aspergillosis
por: Sahu, Monalisa, et al.
Publicado: (2022)

14.1 Clinical spectrum and outcome in 100 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2008)

S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria
por: Davies, Adeyinka, et al.
Publicado: (2022)

P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive
por: Setianingrum, Findra, et al.
Publicado: (2022)

P408 Evaluation of fungal serum biomarkers in the diagnosis and for monitoring patients with post tuberculosis chronic pulmonary aspergillosis
por: Singh, Shreya, et al.
Publicado: (2022)

P203 Chronic pulmonary aspergillosis (CPA) in post tuberculosis sequele— aclinical experience from tertiary care
por: Gupta, Chhavi, et al.
Publicado: (2022)

P128 Chronic pulmonary aspergillosis in a Tuberculosis c enter of Assam—a 2-year study
por: K, Aishwarya, et al.
Publicado: (2022)

S4.2d Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis
por: Ray, Animesh, et al.
Publicado: (2022)

Resurgence of Global Opportunistic Multidrug-resistant Stenotrophomonas maltophilia
por: Gupta, Pradheer, et al.
Publicado: (2018)

P080 Comparison of efficacy of innovator molecule of itraconazole with generic forms of itraconazole in treatment naïve subjects with chronic pulmonary aspergillosis
por: Sehgal, Inderpaul, et al.
Publicado: (2022)

P143 Incidence of chronic pulmonary aspergillosis in a cohort of bacteriologically confirmed TB patients at a tertiary hospital in Ghana
por: Ocansey, Bright, et al.
Publicado: (2022)

P419 Galactomannan enzyme immunoassay in invasive pulmonary aspergillosis: a cross sectional study in 2021 in a New Delhi
por: Das, Sutapa
Publicado: (2022)

P465 Aspergillosis in free-ranging Magellanic penguins
por: Trápaga, Mariana, et al.
Publicado: (2022)

P014 Prevalence and antifungal susceptibility of Wickerhamomyces anomalus in a tertiary care center
por: Pandey, Abhishek, et al.
Publicado: (2022)

P263 Invasive Pulmonary Aspergillosis (IPA) Among Non-Intubated COVID-19 Patients—a New Age Fungal Storm
por: Raghu, Raghapriya, et al.
Publicado: (2022)

P158 Epidemiology of aspergillosis in Kuwait: a nationwide study
por: Alobaid, Khaled, et al.
Publicado: (2022)

P287 A case of cerebral aspergillosis in Sri Lanka
por: Welagedara, P.G.R.I.S., et al.
Publicado: (2022)

MR visible only lesions: what are the predictors for malignant outcome?
por: Bhattacharyya, M, et al.
Publicado: (2010)

P377 Study of the prevalence of candidemia and its antifungal susceptibility pattern in a tertiary care hospital
por: Sharma, Alisha, et al.
Publicado: (2022)

P460 The Aspergillus Lateral Flow Assay for the diagnosis of invasive Aspergillosis
por: Liu, Chonglong, et al.
Publicado: (2022)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

Incidence, Microbiological Profile, and Impact of Preventive Measures on Central Line-associated Bloodstream Infection in Liver Care Intensive Care Unit
por: Khodare, Arvind, et al.
Publicado: (2020)

S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples
por: Feys, Simon, et al.
Publicado: (2022)

P291 Aspergillosis: another force to reckon with during COVID-19 times
por: Singla, Nidhi, et al.
Publicado: (2022)

P453 Aspergillus and aspergillosis in patients in an intensive care unit with mechanical ventilation
por: Trápaga, Mariana, et al.
Publicado: (2022)

P469 Feline aspergillosis caused by Aspergillus candidus: A case report
por: Fernandez, Norma B., et al.
Publicado: (2022)

P428 Evaluation of Galactomannan enzyme assay in non-hematological non-neutropenic ICU admitted patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019
por: Kashyap, Sanchi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_crh2rs9vp01aamh2d89uh39jff